{"title":"Corrigendum to “HDR Brachytherapy in the Management of High-Risk Prostate Cancer”","authors":"S. Masson, R. Persad, A. Bahl","doi":"10.1155/2016/6345816","DOIUrl":null,"url":null,"abstract":"[This corrects the article DOI: 10.1155/2012/980841.].","PeriodicalId":7490,"journal":{"name":"Advances in Urology","volume":"2016 1","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2016-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/6345816","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Urology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2016/6345816","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
[This corrects the article DOI: 10.1155/2012/980841.].
期刊介绍:
Advances in Urology is a peer-reviewed, open access journal that publishes state-of-the-art reviews and original research papers of wide interest in all fields of urology. The journal strives to provide publication of important manuscripts to the widest possible audience worldwide, without the constraints of expensive, hard-to-access, traditional bound journals. Advances in Urology is designed to improve publication access of both well-established urologic scientists and less well-established writers, by allowing interested scientists worldwide to participate fully.